UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
For the quarterly period ended June 30, 2020
or
OF 1934
For the transition period from _________ to __________
COMMISSION FILE NUMBER 1-33926
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of | (I.R.S. Employer Identification No.) |
incorporation or organization) | |
(Address of principal executive offices) | (Zip code) | |
Registrant's telephone number, including area code: (281) 980-5522
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S–T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes X No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☒
Non-accelerated filer ☐ Smaller reporting company ☒
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.____
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Number of shares of the Registrant's Common Stock (par value $0.10 per share) outstanding at July 31, 2020: 24,714,980 .
TABLE OF CONTENTS
Item Number and Description
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
June 30, 2020 (Unaudited) | December 31, 2019 | |||||||
ASSETS | (thousands of dollars, except par value) | |||||||
Current Assets | ||||||||
Cash | $ | $ | ||||||
Trade receivables, net | ||||||||
Inventories | ||||||||
Investment in AMAK (held-for-sale) | ||||||||
Prepaid expenses and other assets | ||||||||
Taxes receivable | ||||||||
Total current assets | ||||||||
Plant, pipeline and equipment, net | ||||||||
Intangible assets, net | ||||||||
Lease right-of-use assets, net | ||||||||
Mineral properties in the United States | ||||||||
TOTAL ASSETS | $ | $ | ||||||
LIABILITIES | ||||||||
Current Liabilities | ||||||||
Accounts payable | $ | $ | ||||||
Accrued liabilities | ||||||||
Current portion of long-term debt | ||||||||
Current portion of lease liabilities | ||||||||
Current portion of other liabilities | ||||||||
Total current liabilities | ||||||||
CARES Act, PPP Loans | ||||||||
Long-term debt, net of current portion | ||||||||
Post-retirement benefit, net of current portion | ||||||||
Lease liabilities, net of current portion | ||||||||
Other liabilities, net of current portion | ||||||||
Deferred income taxes | ||||||||
Total liabilities | ||||||||
EQUITY | ||||||||
Common stock‑authorized 40 million shares of $0.10 par value; issued and outstanding 24.8 million and 24.8 million in 2020 and 2019, respectively | ||||||||
Additional paid-in capital | ||||||||
Retained earnings | ||||||||
Total Trecora Resources Stockholders' Equity | ||||||||
Noncontrolling Interest | ||||||||
Total equity | ||||||||
TOTAL LIABILITIES AND EQUITY | $ | $ | ||||||
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
THREE MONTHS ENDED JUNE 30, | SIX MONTHS ENDED JUNE 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
(thousands of dollars, except per share amounts) | ||||||||||||||||
REVENUES | ||||||||||||||||
Product sales | $ | $ | $ | $ | ||||||||||||
Processing fees | ||||||||||||||||
OPERATING COSTS AND EXPENSES | ||||||||||||||||
Cost of sales and processing | ||||||||||||||||
(including depreciation and amortization of $3,750, $4,128, $7,486 and $8,357, respectively) | ||||||||||||||||
GROSS PROFIT | ||||||||||||||||
GENERAL AND ADMINISTRATIVE EXPENSES | ||||||||||||||||
General and administrative | ||||||||||||||||
Depreciation | ||||||||||||||||
OPERATING INCOME (LOSS) | ( | ) | ||||||||||||||
OTHER INCOME (EXPENSE) | ||||||||||||||||
Interest income | ||||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Miscellaneous income, net | ||||||||||||||||
( | ) | ( | ) | ( | ) | ( | ) | |||||||||
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES | ( | ) | ( | ) | ||||||||||||
INCOME TAX EXPENSE (BENEFIT) | ( | ) | ||||||||||||||
INCOME (LOSS) FROM CONTINUING OPERATIONS | ( | ) | ||||||||||||||
INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX | ( | ) | ( | ) | ( | ) | ||||||||||
NET INCOME (LOSS) | $ | ( | ) | $ | $ | $ | ||||||||||
Basic Earnings per Common Share | ||||||||||||||||
Net income (loss) from continuing operations (dollars) | $ | ( | ) | $ | $ | $ | ||||||||||
Net income (loss) from discontinued operations, net of tax (dollars) | ( | ) | ||||||||||||||
Net income (loss) (dollars) | $ | ( | ) | $ | $ | $ | ||||||||||
Basic weighted average number of common shares outstanding | ||||||||||||||||
Diluted Earnings per Common Share | ||||||||||||||||
Net income (loss) from continuing operations (dollars) | $ | ( | ) | $ | $ | $ | ||||||||||
Net income (loss) from discontinued operations, net of tax (dollars) | ( | ) | ||||||||||||||
Net income (loss) (dollars) | $ | ( | ) | $ | $ | $ | ||||||||||
Diluted weighted average number of common shares outstanding | ||||||||||||||||
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)
THREE MONTHS ENDED JUNE 30
TRECORA RESOURCES STOCKHOLDERS | |||||||||||||||||||||||||||||||
COMMON STOCK | ADDITIONAL PAID-IN | TREASURY | RETAINED | NON- CONTROLLING | TOTAL | ||||||||||||||||||||||||||
SHARES | AMOUNT | CAPITAL | STOCK | EARNINGS | TOTAL | INTEREST | EQUITY | ||||||||||||||||||||||||
(thousands) | (thousands of dollars) | ||||||||||||||||||||||||||||||
March 31, 2020 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Restricted Stock Units | |||||||||||||||||||||||||||||||
Issued to Directors | — | — | — | — | — | ||||||||||||||||||||||||||
Issued to Employees | — | — | — | — | — | ||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||
Issued to Directors | ( | ) | — | — | — | ||||||||||||||||||||||||||
Issued to Employees | ( | ) | — | — | — | ||||||||||||||||||||||||||
Net Income | — | — | — | — | ( | ) | ( | ) | — | ( | ) | ||||||||||||||||||||
June 30, 2020 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
March 31, 2019 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ||||||||||||||||||||||
Restricted Stock Units | |||||||||||||||||||||||||||||||
Issued to Directors | — | — | — | — | — | ||||||||||||||||||||||||||
Issued to Employees | — | — | — | — | — | ||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||
Issued to Directors | — | — | — | ||||||||||||||||||||||||||||
Issued to Employees | — | — | — | — | |||||||||||||||||||||||||||
Net Income | — | — | — | — | — | ||||||||||||||||||||||||||
June 30, 2019 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ||||||||||||||||||||||
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)
SIX MONTHS ENDED JUNE 30
TRECORA RESOURCES STOCKHOLDERS | |||||||||||||||||||||||||||||||
COMMON STOCK | ADDITIONAL PAID-IN | TREASURY | RETAINED | NON- CONTROLLING | TOTAL | ||||||||||||||||||||||||||
SHARES | AMOUNT | CAPITAL | STOCK | EARNINGS | TOTAL | INTEREST | EQUITY | ||||||||||||||||||||||||
(thousands) | (thousands of dollars) | ||||||||||||||||||||||||||||||
January 1, 2020 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Restricted Stock Units | |||||||||||||||||||||||||||||||
Issued to Directors | — | — | — | — | — | ||||||||||||||||||||||||||
Issued to Employees | — | — | — | — | — | ||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||
Issued to Directors | ( | ) | — | — | — | — | — | ||||||||||||||||||||||||
Issued to Employees | ( | ) | — | — | — | ||||||||||||||||||||||||||
Net Income | — | — | — | — | — | ||||||||||||||||||||||||||
June 30, 2020 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
January 1, 2019 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ||||||||||||||||||||||
Restricted Stock Units | |||||||||||||||||||||||||||||||
Issued to Directors | — | — | — | — | — | ||||||||||||||||||||||||||
Issued to Employees | — | — | — | — | — | ||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||
Issued to Directors | — | — | — | ||||||||||||||||||||||||||||
Issued to Employees | — | — | — | ||||||||||||||||||||||||||||
Net Income | — | — | — | — | — | ||||||||||||||||||||||||||
June 30, 2019 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ||||||||||||||||||||||
TRECORA RESOURCES AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
SIX MONTHS ENDED JUNE 30, | ||||||||
2020 | 2019 | |||||||
(thousands of dollars) | ||||||||
OPERATING ACTIVITIES | ||||||||
Net Income | $ | $ | ||||||
Income (Loss) from Discontinued Operations | ( | ) | ||||||
Income from Continuing Operations | $ | $ | ||||||
Adjustments to Reconcile Income from Continuing Operations To Net Cash Provided by Operating Activities: | ||||||||
Depreciation and Amortization | ||||||||
Amortization of Intangible Assets | ||||||||
Stock-based Compensation | ||||||||
Deferred Income Taxes | ||||||||
Postretirement Obligation | ( | ) | ||||||
Amortization of Loan Fees | ||||||||
Loss on Disposal of Assets | ||||||||
Changes in Operating Assets and Liabilities: | ||||||||
Decrease (Increase) in Trade Receivables | ( | ) | ||||||
Decrease in Insurance Receivables | ||||||||
Increase in Taxes Receivable | ( | ) | ||||||
Decrease in Inventories | ||||||||
Decrease in Prepaid Expenses and Other Assets | ||||||||
Decrease in Accounts Payable and Accrued Liabilities | ( | ) | ( | ) | ||||
Decrease in Other Liabilities | ||||||||
Net Cash Provided by Operating Activities - Continuing Operations | ||||||||
Net Cash Used in Operating Activities - Discontinued Operations | ( | ) | ( | ) | ||||
Net Cash Provided by Operating Activities | ||||||||
INVESTING ACTIVITIES | ||||||||
Additions to Plant, Pipeline and Equipment | ( | ) | ( | ) | ||||
Proceeds from PEVM | ||||||||
Net Cash Used in Investing Activities - Continuing Operations | ( | ) | ( | ) | ||||
Net Cash Provided by Investing Activities - Discontinued Operations | ||||||||
Net Cash Provided by (Used in) Investing Activities | ( | ) | ||||||
FINANCING ACTIVITIES | ||||||||
Net Cash Paid Related to Stock-Based Compensation | ( | ) | ( | ) | ||||
Additions to CARES Act, PPP Loans | ||||||||
Additions to Long-Term Debt | ||||||||
Repayments of Long-Term Debt | ( | ) | ( | ) | ||||
Net Cash Provided by (Used in) Financing Activities - Continuing Operations | ( | ) | ||||||
NET INCREASE (DECREASE) IN CASH | ( | ) | ||||||
CASH AT BEGINNING OF PERIOD | ||||||||
CASH AT END OF PERIOD | $ | $ | ||||||
Supplemental disclosure of cash flow information: | ||||||||
Cash payments for interest | $ | $ | ||||||
Cash payments for taxes, net of refunds | $ | $ | ||||||
Supplemental disclosure of non-cash items: | ||||||||
Capital expansion amortized to depreciation expense | $ | $ | ||||||
Foreign taxes paid by AMAK | $ | $ | ||||||
See notes to consolidated financial statements.
TRECORA RESOURCES AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
1. GENERAL
Organization
Trecora Resources (the "Company" or "TREC") was incorporated in the State of Delaware in 1967. Our principal business activities are the manufacturing of various specialty hydrocarbons and specialty waxes and the provision of custom processing services. Unless the context requires otherwise, references to "we," "us," "our," "TREC," and the "Company" are intended to mean Trecora Resources and its subsidiaries.
This document includes the following abbreviations:
(1) | TOCCO – Texas Oil & Chemical Co. II, Inc. – Wholly owned subsidiary of TREC and parent of SHR and TC |
(2) | SHR – South Hampton Resources, Inc. – Specialty Petrochemicals segment and parent of GSPL |
(3) | GSPL – Gulf State Pipe Line Co, Inc. – Pipeline support for the Specialty Petrochemicals segment |
(4) | TC – Trecora Chemical, Inc. – Specialty Waxes segment |
(5) | AMAK – Al Masane Al Kobra Mining Company – Held-for-sale mining equity investment – |
(6) | PEVM – Pioche Ely Valley Mines, Inc. – Inactive mine – |
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and, therefore, should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2019.
The unaudited condensed consolidated financial statements included in this document have been prepared on the same basis as the annual financial statements and in management's opinion reflect all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial position, results of operations and cash flows for the interim periods presented. We have made estimates and judgments affecting the amounts reported in this document. The actual results that we experience may differ materially from our estimates. In the opinion of management, the disclosures included in these financial statements are adequate to make the information presented not misleading.
Operating results for the six months ended June 30, 2020 are not necessarily indicative of results for the year ending December 31, 2020.
We currently operate in two segments, Specialty Petrochemicals and Specialty Waxes. All revenue originates from sources in the United States, and all long-lived assets owned are located in the United States.
In addition, we own a 28.3 % interest in AMAK, a Saudi Arabian closed joint stock company, which owns, operates and is developing mining assets in Saudi Arabia. Our investment is classified as held-for-sale and and the equity in earnings (losses) are recorded in discontinued operations. See Note 5.
2. RECENT ACCOUNTING PRONOUNCEMENTS
Recently Adopted Accounting Pronouncements
Effective January 1, 2020, we adopted Financial Accounting Standard Board ("FASB") Accounting Standards Update ("ASU") 2016-13, Measurement of Credit Losses on Financial Instruments, which changed the way entities recognize impairment of most financial assets. Short-term and long-term financial assets, as defined by the standard, are impacted by immediate recognition of estimated credit losses in the financial statements, reflecting the net amount expected to be collected. The adoption of this standard did not have a material impact on our condensed consolidated financial statements.
Recent Accounting Pronouncements Not Yet Adopted
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for us in the first quarter of 2021 on a prospective basis, and early adoption is permitted. We are currently evaluating the impact of the new guidance on our condensed consolidated financial statements.
In March 2020, the FASB issued ASU No. 2020–04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (ASU 2020-04), which provides guidance to alleviate the burden in accounting for reference rate reform by allowing certain expedients and exceptions in applying generally accepted accounting principles to contracts, hedging relationships, and other transactions impacted by reference rate reform. The provisions of ASU 2020-04 apply only to those transactions that reference LIBOR or another reference rate expected to be discontinued due to reference rate reform. Adoption of the provisions of ASU 2020-04 are optional and are effective from March 12, 2020 through December 31, 2022. We are currently evaluating the impact of ASU 2020-04 on our condensed consolidated financial statements.
3. TRADE RECEIVABLES
Trade receivables, net, consisted of the following:
June 30, 2020 | December 31, 2019 | |||||||
(thousands of dollars) | ||||||||
Trade receivables | $ | $ | ||||||
Less allowance for doubtful accounts | ( | ) | ( | ) | ||||
Trade receivables, net | $ | $ | ||||||
Trade receivables serve as collateral for our amended and restated credit agreement. See Note 11.
4. INVENTORIES
Inventories included the following:
June 30, 2020 | December 31, 2019 | |||||||
(thousands of dollars) | ||||||||
Raw material | $ | $ | ||||||
Work in process | ||||||||
Finished products | ||||||||
Total inventory | $ | $ | ||||||
Inventory serves as collateral for our amended and restated credit agreement. See Note 11.
Inventory included Specialty Petrochemicals products in transit valued at approximately $1.4 million and $2.9 million at June 30, 2020 and December 31, 2019, respectively.
5. INVESTMENT IN AMAK (Held-for-Sale)
As of June 30, 2020 and December 31, 2019, the Company had a non-controlling equity interest of 28.3 % and 33.3 % in AMAK of approximately $29.2 million and $32.9 million, respectively. This investment is accounted for under the equity method. There were no events or changes in circumstances that had an adverse effect on the fair value of our investment in AMAK at June 30, 2020.
The Company committed to a plan to sell our investment in AMAK during the third quarter of 2019. Management engaged in a comprehensive process to market the investment to numerous potential buyers. The process resulted in an agreement with certain AMAK stockholders in September 2019 to purchase our investment. Pursuant to a Share Sale and Purchase Agreement (as amended, the "Purchase Agreement") that was effective as of October 2, 2019, the Company agreed to sell its entire equity interest in AMAK, to AMAK and certain other existing stockholders of AMAK (collectively, the "Purchasers")
for an aggregate gross purchase price (before taxes and transaction expenses) of Saudi Riyals ("SAR") 264.7 million (or approximately US$70 million), which will be payable in US Dollars (collectively, the "Share Sale"). The Purchasers advanced 5 % of the purchase price (or approximately $3.5 million) in the form of a non-refundable deposit, which was a condition to the effectiveness of the Purchase Agreement. The Purchase Agreement contained various representations, warranties and indemnity obligations of the Company and the Purchasers, including the release of the Company's guarantee as described in Note 12.
On January 16, 2020, the Company and the Purchasers entered into a letter agreement (the “January 2020 Amendment”) providing certain amendments to the Purchase Agreement. Pursuant to the January 2020 Amendment, the Long Stop Date (as defined in the Purchase Agreement) for completion of the Share Sale was extended to March 31, 2020 to allow additional time for the parties to obtain certain required governmental approvals. Under the Purchase Agreement, the Company had certain termination rights if closing of the Share Sale did not occur on or before the Long Stop Date. The January 2020 Amendment also provided that, if closing of the Share Sale does not occur on or before the extended Long Stop Date, and the Company determined in its sole discretion to further extend such date, then an amount equal to 50 % of the approximately $3.5 million non-refundable deposit made by the Purchasers under the Purchase Agreement would be forfeited to the Company as liquidated damages and would not be applied to the purchase price at closing of the Share Sale.
Effective as of March 26, 2020, the Company and the Purchasers entered into a letter agreement, dated March 23, 2020 (the “March 2020 Amendment”), providing for certain additional amendments to the Purchase Agreement.
Pursuant to the March 2020 Amendment, the Company and the Purchasers agreed that the Share Sale may be completed with the respective Purchasers in multiple closings, in each case, subject to the completion of any remaining conditions precedent. To the extent that a Purchaser completed the purchase of all or a portion of the ordinary shares allotted to it under the Purchase Agreement on or before March 31, 2020, the non-refundable deposit paid by such Purchaser (or a portion of such deposit for a partial closing) was credited toward the purchase price of the ordinary shares being purchased. Purchasers that complete the purchase of all or a portion of their allotted ordinary shares after March 31, 2020 but on or before September 28, 2020 (the “New Long Stop Date”), will forfeit an amount equal to 50 % of the non-refundable deposit paid by such Purchasers to the Company as liquidated damages and such amount shall not be applied to the purchase price paid by the applicable Purchaser. With respect to any Purchaser that has not completed the purchase of 100 % of its allocated ordinary shares on or prior to the New Long Stop Date, (i) any remaining amount of non-refundable deposit paid by such Purchaser will be forfeited to the Company as liquidated damages as of September 29, 2020 and (ii) the Company may terminate the Purchase Agreement in accordance with its terms unless the Company elects, in its sole discretion, to further extend the New Long Stop Date.
On March 26, 2020, the Company and one Purchaser, Arab Mining Company, completed the first closing of the Share Sale (the “First Closing”). In connection with the First Closing, the Company sold 4,000,000 ordinary shares for an aggregate gross purchase price (before taxes and transaction expenses) of SAR 40 million (or approximately US$10.7 million) (inclusive of the credited amount of the Purchaser’s non-refundable deposit previously paid of US$0.5 million). The First Closing also included indemnification provisions which effectively reduced our portion of the loan guarantee (as discussed in Note 12). We recorded a foreign tax payable of approximately $0.3 million related to this transaction. Upon payment, this amount will be a foreign tax credit used to offset U.S. taxes.
Pursuant to the March 2020 Amendment, the remaining Purchasers have agreed to use their best efforts to close the purchase of 100 % of their respective allotments of ordinary shares as soon as possible. The March 2020 Amendment also provides that the Company will continue to have the right to appoint three directors of the board of directors of AMAK, and will enjoy all other governance rights it currently has, until the Share Sale has been completed in full. As no other transactions closed through March 31, 2020, approximately $1.5 million of the initial deposits were forfeited to the Company as liquidated damages and will not be applied to the purchase price at closing. This amount was recorded as an increase to our investment in AMAK and a gain on sale of equity interest in discontinued operations.
As all the required criteria for held-for-sale classification was met in third quarter of 2019, the investment in AMAK is classified as held-for-sale in the Consolidated Balance Sheets and reflected as discontinued operations in the Consolidated Statements of Operations for all periods presented. The assets held-for-sale are disclosed by the Company in the Corporate segment. The Company expects to have no continuing involvement with the discontinued operations after the closing date. The gain (loss) from discontinued operations, net of tax, includes our portion of the equity in earnings (losses) in AMAK, forfeited deposits, other administrative expenses incurred in Saudi Arabia and transaction costs.
Included in discontinued operations are the following:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
(thousands of dollars) | (thousands of dollars) | |||||||||||||||
Saudi administration (income) expenses | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
Equity in (earnings) losses of AMAK | ( | ) | ||||||||||||||
Gain on sale of equity interest | ( | ) | ||||||||||||||
(Income) loss from discontinued operations before taxes | ( | ) | ( | ) | ||||||||||||
Tax expense (benefit) | ( | ) | ( | ) | ||||||||||||
(Income) loss from discontinued operations (net of tax) | $ | $ | $ | ( | ) | $ | ||||||||||
AMAK's financial statements were prepared in the functional currency of AMAK which is the SAR. In June 1986 the SAR was officially pegged to the U. S. Dollar at a fixed exchange rate of 1 USD to 3.75 SAR.
The summarized results of operation and financial position for AMAK are as follows:
Results of Operations
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
(thousands of dollars) | (thousands of dollars) | |||||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||
Cost of sales | ||||||||||||||||
Gross profit | ||||||||||||||||
Selling, general, and administrative | ||||||||||||||||
Operating income (loss) | ( | ) | ( | ) | ( | ) | ||||||||||
Other income (expense) | ( | ) | ||||||||||||||
Finance and interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Income (loss) before Zakat and income taxes | ( | ) | ( | ) | ( | ) | ||||||||||
Zakat and income taxes | ||||||||||||||||
Net Loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Financial Position
June 30, | December 31, | |||||||
2020 | 2019 | |||||||
(thousands of dollars) | ||||||||
Current assets | $ | $ | ||||||
Noncurrent assets | ||||||||
Total assets | $ | $ | ||||||
Current liabilities | $ | $ | ||||||
Long term liabilities | ||||||||
Stockholders' equity | ||||||||
$ | $ | |||||||
Changes in Ownership
• | In the first quarter of 2020, we completed a portion of the Share Sale to an existing shareholder of AMAK. We sold |
occurred at the end of the first quarter, our portion of the equity in earnings/losses of AMAK reflected for the first quarter of 2020 is calculated at 33.3 %, whereas our ownership of balance sheet accounts is reflected at 28.3 % as of March 31, 2020.
• | In the second quarter of 2019, certain shareholders of AMAK transferred a portion of their shares to the CEO of AMAK as a one-time retention and performance bonus. The Company transferred |
The equity in the earnings (losses) of AMAK included in income (loss) from discontinued operations, net of tax, on the consolidated statements of operations for the three and six months ended June 30, 2020 and 2019, is comprised of the following:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||
(thousands of dollars) | (thousands of dollars) | |||||||||||
AMAK Net Loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||
Percentage of Ownership | % | % | % | * | % | |||||||
Company's share of loss reported by AMAK | ( | ) | ( | ) | ( | ) | ( | ) | ||||
Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK | ||||||||||||
Equity in earnings (losses) of AMAK | ( | ) | ( | ) | ( | ) | ||||||
* Percentage of Ownership varies during the period. | ||||||||||||
For additional information, see NOTE 6, "INVESTMENT IN AMAK AND DISCONTINUED OPERATIONS" to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2019.
6. PREPAID EXPENSES AND OTHER ASSETS
Prepaid expenses and other assets consisted of the following:
June 30, 2020 | December 31, 2019 | |||||||
(thousands of dollars) | ||||||||
Prepaid license | $ | $ | ||||||
Spare parts | ||||||||
Insurance receivable | ||||||||
Other prepaid expenses and assets | ||||||||
Total prepaid expenses and other assets | $ | $ | ||||||
7. PLANT, PIPELINE AND EQUIPMENT
Plant, pipeline and equipment consisted of the following:
June 30, 2020 | December 31, 2019 | |||||||
(thousands of dollars) | ||||||||
Platinum catalyst metal | $ | $ | ||||||
Catalyst | ||||||||
Land | ||||||||
Plant, pipeline and equipment | ||||||||
Construction in progress | ||||||||
Total plant, pipeline and equipment | $ | $ | ||||||
Less accumulated depreciation | ( | ) | ( | ) | ||||
Net plant, pipeline and equipment | $ | $ | ||||||
Plant, pipeline, and equipment serve as collateral for our amended and restated credit agreement. See Note 11.
Construction in progress during the first six months of 2020 included Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC. Construction in progress during the first six months of 2019 included equipment purchased for various equipment updates at the TC facility, the Advanced Reformer unit, tankage upgrades, and an addition to the rail spur at SHR.
Amortization relating to the catalyst, which is included in cost of sales, was approximately $0.2 million and $0.2 million for the three months and $0.4 million and $0.5 million for the six months ended June 30, 2020 and 2019, respectively.
8. LEASES
The Company leases certain rail cars, rail equipment, office space and office equipment. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and accounts for these options when they are reasonably certain of being exercised.
Leases with an initial term of 12 months or less are not recorded on the Condensed Consolidated Balance Sheets. Lease expense for these leases is recognized on a straight-line basis over the lease term.
The Company has no finance leases.
The components of lease expense were as follows:
($ in thousands) | Classification in the Condensed Consolidated Statements of Income | Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Operating lease cost (a) | Cost of sales, exclusive of depreciation and amortization | $ | $ | $ | $ | |||||||||||
Operating lease cost (a) | Selling, general and administrative | |||||||||||||||
Total lease cost | $ | $ | $ | $ | ||||||||||||
(a) Short-term lease costs were approximately $0.1 million and $0.1 million for the three months ended June 30, 2020 and 2019, respectively. Short-term lease costs were approximately $0.1 million and $0.1 million for the six months ended June 30, 2020 and 2019, respectively. | ||||||||||||||||
The Company had no variable lease expense, as defined by ASC 842, during the periods.
($ in thousands) | Classification on the Condensed Consolidated Balance Sheets | June 30, 2020 | December 31, 2019 | |||||
Assets: | ||||||||
Operating | Operating lease assets | $ | $ | |||||
Total leased assets | $ | $ | ||||||
Liabilities: | ||||||||
Current: | ||||||||
Operating | Current portion of operating lease liabilities | $ | $ | |||||
Noncurrent: | ||||||||
Operating | Operating lease liabilities | |||||||
Total lease liabilities | $ | $ | ||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
($ in thousands) | 2020 | 2019 | 2020 | 2019 | |||||||||||
Cash paid for amounts included in the measurement of lease liabilities: | |||||||||||||||
Operating cash flows used for operating leases | $ | $ | $ | $ | |||||||||||
Right-of-use assets obtained in exchange for lease obligations: | |||||||||||||||
Operating leases | $ | $ | $ | $ | |||||||||||
June 30, 2020 | ||
Weighted-average remaining lease term (in years): | ||
Operating leases | ||
Weighted-average discount rate: | ||
Operating leases | % | |
Nearly all of the Company’s lease contracts do not provide a readily determinable implicit rate. For these contracts, the Company’s estimated incremental borrowing rate is based on information available at the inception of the lease.
As of June 30, 2020, maturities of lease liabilities were as follows:
($ in thousands) | Operating Leases | ||
2020 | $ | ||
2021 | |||
2022 | |||
2023 | |||
2024 | |||
Thereafter | |||
Total lease payments | $ | ||
Less: Interest | |||
Total lease obligations | $ | ||
9. INTANGIBLE ASSETS, NET
Intangible assets were recorded in relation to the acquisition of TC on October 1, 2014.
The following tables summarize the gross carrying amounts and accumulated amortization of intangible assets by major class:
June 30, 2020 | ||||||||||||
Gross | Accumulated Amortization | Net | ||||||||||
(thousands of dollars) | ||||||||||||
Customer relationships | $ | $ | ( | ) | $ | |||||||
Non-compete agreements | ( | ) | ||||||||||
Licenses and permits | ( | ) | ||||||||||
Developed technology | ( | ) | ||||||||||
Total | $ | $ | ( | ) | $ | |||||||
December 31, 2019 | ||||||||||||
Gross | Accumulated Amortization | Net | ||||||||||
(thousands of dollars) | ||||||||||||
Customer relationships | $ | $ | ( | ) | $ | |||||||
Non-compete agreements | ( | ) | ||||||||||
Licenses and permits | ( | ) | ||||||||||
Developed technology | ( | ) | ||||||||||
Total | $ | $ | ( | ) | $ | |||||||
Amortization expense for intangible assets included in cost of sales was approximately $0.5 million and $0.5 million for the three months and approximately $0.9 million and $0.9 million for the six months ended June 30, 2020 and 2019, respectively.
Based on identified intangible assets that are subject to amortization as of June 30, 2020, we expect future amortization expenses for each period to be as follows:
Total | Remainder of 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Thereafter | |||||||||||||||||||||||||
(thousands of dollars) | ||||||||||||||||||||||||||||||||
Customer relationships | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Licenses and permits | ||||||||||||||||||||||||||||||||
Developed technology | ||||||||||||||||||||||||||||||||
Total future amortization expense | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
10. ACCRUED LIABILITIES
Accrued liabilities consisted of the following:
June 30, 2020 | December 31, 2019 | |||||||
(thousands of dollars) | ||||||||
State taxes | $ | $ | ||||||
Property taxes | ||||||||
Payroll | ||||||||
Royalties | ||||||||
Officer compensation | ||||||||
Legal | ||||||||
Foreign taxes | ||||||||
AMAK transaction costs | ||||||||
Other | ||||||||
Total | $ | $ | ||||||
11. LIABILITIES AND LONG-TERM DEBT
Senior Secured Credit Facilities
As of June 30, 2020, we had nil in borrowings outstanding under the revolving credit facility (the "Revolving Facility") of our amended and restated credit agreement (as amended to the date hereof, the "ARC Agreement") and approximately $78.2 million in borrowings outstanding under the term loan facility of the ARC Agreement (the "Term Loan Facility" and, together with the Revolving Facility, the "Credit Facilities"). In addition, we had approximately $27 million of availability under our Revolving Facility at June 30, 2020. TOCCO’s ability to make additional borrowings under the Revolving Facility at June 30, 2020 was limited by, and in the future may be limited by, our obligation to maintain compliance with the covenants contained in the ARC Agreement (including maintenance of a maximum Consolidated Leverage Ratio and minimum Consolidated Fixed Charge Coverage Ratio (each as defined in the ARC Agreement)).
On May 8, 2020, TOCCO, SHR, GSPL and TC entered into a Seventh Amendment to the ARC Agreement. Pursuant to the Seventh Amendment, certain amendments were made to the terms of the ARC Agreement, including, among other things, to (a) permit the incurrence of additional indebtedness in the form of loans (the "PPP Loans") under the United States Small Business Administration Paycheck Protection Program (the "PPP") and (b) exclude the PPP Loans from the calculation of the Consolidated Leverage Ratio until such time that any portion of the PPP Loans are not forgiven in accordance with the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act").
For each fiscal quarter after December 31, 2019, TOCCO must maintain a maximum Consolidated Leverage Ratio of 3.50 to 1.00 (subject to temporary increase following certain acquisitions). TOCCO's Consolidated Leverage Ratio was 2.62 and 2.91 as of June 30, 2020 and March 31, 2020, respectively. Additionally, TOCCO must maintain a minimum Consolidated Fixed Charge Coverage Ratio as of the end of any fiscal quarter of 1.15 to 1.00. TOCCO's Consolidated Fixed Charge Coverage Ratio was 1.98 and 2.21 as of June 30, 2020 and December 31, 2019, respectively. As noted above, the Consolidated Leverage Ratio specifically excludes the PPP Loans until such time that any portion of the PPP Loans are not forgiven in accordance with the CARES Act.
The maturity date for the ARC Agreement is July 31, 2023. As of June 30, 2020, the effective interest rate for the Credit Facilities was 2.52 %. The ARC Agreement contains a number of customary affirmative and negative covenants and we were in compliance with those covenants as of June 30, 2020.
For a summary of additional terms of the Credit Facilities, see NOTE 13, “LONG-TERM DEBT AND LONG-TERM OBLIGATIONS" to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2019.
PPP Loans
On May 6, 2020, SHR and TC (collectively, the “Borrowers") received loan proceeds from the PPP Loans in an aggregate principal amount of approximately $6.1 million under the PPP. The PPP Loans are evidenced by unsecured promissory notes each payable to Bank of America, N.A. The Borrowers plan to use the PPP Loans to cover payroll costs and certain other eligible expenses in accordance with the relevant terms and conditions of the CARES Act. The PPP Loans mature on May 6, 2022, and bear interest at a stated rate of 1.0 % per annum. The PPP Loans may be partially or fully forgiven if the Borrowers comply with the provisions of the CARES Act.
Debt Issuance Costs
Debt issuance costs of approximately $0.9 million were incurred in connection with the fourth amendment to the ARC Agreement. Unamortized debt issuance costs of approximately $0.6 million and $0.6 million for the periods ended June 30, 2020 and December 31, 2019, have been netted against outstanding loan balances.
Long-term debt and long-term obligations are summarized as follows:
June 30, 2020 | December 31, 2019 | ||||
(thousands of dollars) | |||||
Revolving Facility | |||||
Term Loan Facility | |||||
Loan fees | ( | ) | ( | ) | |
Total long-term debt | |||||
Less current portion including loan fees | |||||
Total long-term debt, less current portion including loan fees | |||||
12. COMMITMENTS AND CONTINGENCIES
COVID-19
The global outbreak of COVID-19 presents various global risks. The full impact of the outbreak continues to evolve as of the date of this report. The COVID-19 pandemic has had an impact on our business, results of operations, financial position and liquidity for the second quarter of 2020. In the second quarter we saw reduced demand in certain end markets (in particular, durable consumer goods), which we attribute to the economic slowdown caused by the COVID-19 pandemic. This weakened demand in certain end markets is likely to continue in the near-term and may continue for the remainder of 2020 and into 2021. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects, if any, on its results of operations, financial condition, or liquidity for fiscal year 2020 or 2021.
Guarantees
On October 24, 2010, we executed a limited guarantee in favor of the Saudi Industrial Development Fund ("SIDF") whereby we agreed to guaranty up to 41 % of the SIDF loan (the "Loan") to AMAK. As a condition of the Loan, SIDF required all stockholders of AMAK to execute personal or corporate guarantees. The Loan was necessary to continue construction of the AMAK facilities and provide working capital needs. We received no consideration in connection with extending the guarantee and did so to maintain and enhance the value of our investment. On July 8, 2018, the Loan was amended to adjust the repayment schedule and extend the repayment terms through April 2024. Under the new payment terms the current amount due in 2020 is SAR 50.0 million (US$13.3 million). In connection with the First Closing discussed in Note 5, our portion of the loan guarantee was effectively reduced to 33.1 % or approximately SAR 95.7 million (US$24.3 million). The total amount outstanding on the Loan at June 30, 2020 was SAR 275.0 million (US$77.3 million). The Purchase Agreement described in Note 5 includes the release of the Company's entire guarantee in connection with the Share Sale. See additional discussion in Note 5.
Operating Lease Commitments
See Note 8 for discussion on lease commitments.
Litigation
The Company is periodically named in legal actions arising from normal business activities. We evaluate the merits of these actions and, if we determine that an unfavorable outcome is probable and can be reasonably estimated, we will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.
Supplier Agreements
In accordance with our supplier agreements, on a recurring monthly basis, the Company commits to purchasing a determined volume of feedstock in anticipation of upcoming requirements. Feedstock purchases are invoiced and recorded when they are
delivered. As of June 30, 2020 and December 31, 2019, the value of the remaining undelivered feedstock approximated $2.7 million and $3.5 million, respectively.
From time to time, we may incur shortfall fees due to feedstock purchases being below the minimum amounts prescribed by our agreements with our suppliers. Shortfall fee expenses were approximately $0.6 million and $0.1 million for the three months and $1.0 million and $0.7 million for the six months ended June 30, 2020 and 2019, respectively.
Environmental Remediation
Amounts charged to expense for various activities related to environmental monitoring, compliance, and improvements were approximately $0.3 million and $0.2 million for the three months and $0.5 million and $0.4 million for the six months ended June 30, 2020 and 2019, respectively.
13. STOCK-BASED COMPENSATION
The Stock Option Plan for Key Employees, as well as, the Non-Employee Director Stock Option Plan (hereinafter collectively referred to as the “Stock Option Plans”), were approved by the Company’s stockholders in July 2008. The Stock Option Plans allot for the issuance of up to 1,000,000 shares.
The Trecora Resources Stock and Incentive Plan (the “Plan”) was approved by the Company’s stockholders in June 2012. As amended, the Plan allots for the issuance of up to 2.5 million shares in the form of stock options or restricted stock unit awards.
The Company recognized stock-based compensation expense of approximately $0.5 million and $0.3 million for the three months and $0.9 million and $0.6 million for the six months ended June 30, 2020 and 2019, respectively.
Stock Options and Warrant Awards
Stock options and warrants granted under the provisions of the Stock Option Plans permit the purchase of our common stock at exercise prices equal to the closing price of Company common stock on the date the options were granted. The options have terms of 10 years and generally vest ratably over terms of 4 to 5 years. There were no stock options or warrant awards issued during the three or six months ended June 30, 2020 or 2019, respectively.
A summary of the status of the Company’s stock option and warrant awards is as follows:
Stock Options and Warrants | Weighted Average Exercise Price Per Share | Weighted Average Remaining Contractual Life | Intrinsic Value (in thousands) | ||||||||
Outstanding at January 1, 2020 | |||||||||||
Granted | |||||||||||
Exercised | |||||||||||
Forfeited | |||||||||||
Outstanding at June 30, 2020 | $ | ||||||||||
Expected to vest | $ | ||||||||||
Exercisable at June 30, 2020 | $ | ||||||||||
The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At June 30, 2020, options to purchase approximately 0.1 million shares of common stock were in-the-money.
Since no options were granted, the weighted average grant-date fair value per share of options granted during the three and six months ended June 30, 2020 and 2019, respectively, was zero .
The Company has no non-vested options as of June 30, 2020.
Restricted Stock Unit Awards
Generally, restricted stock unit awards are granted annually to officers and directors of the Company under the provisions of the Plan. Restricted stock units are also granted ad hoc to attract or retain key personnel, and the terms and conditions under which these restricted stock units vest vary by award. The fair market value of restricted stock units granted is equal to the Company’s closing stock price on the date of grant. Restricted stock units granted generally vest ratably over 3 years. Certain awards also include vesting provisions based on performance metrics. Upon vesting, the restricted stock units are settled by issuing one share of Company common stock per unit.
A summary of the status of the Company's restricted stock units activity is as follows:
Shares of Restricted Stock Units | Weighted Average Grant Date Price per Share | ||||
Outstanding at January 1, 2020 | |||||
Granted | |||||
Forfeited | ( | ) | |||
Vested | ( | ) | |||
Outstanding at June 30, 2020 | |||||
Expected to vest | |||||
14. INCOME TAXES
We file an income tax return in the U.S. federal jurisdiction and a margin tax return in Texas. Previously, the Texas Comptroller selected the R&D credit calculations related to the 2014 and 2015 calendar years for audit. The state of Texas suspended examination of the 2014 and 2015 calendar years in order to perform a comprehensive review of audit procedures to provide consistency. During the fourth quarter of 2019, we received notice that Texas had completed their review of their procedures and initiated additional requests for information. We do not expect any material changes related to the federal or Texas audits. In February 2020, we received notice from the Internal Revenue Service ("IRS") regarding the IRS's selection of the Company for an income tax audit for the tax period ending December 31, 2017. Our federal and Texas tax returns remain open for examination for the years 2016 through 2019. As of June 30, 2020 and December 31, 2019, respectively, we recognized no adjustments for uncertain tax positions or related interest and penalties.
The effective tax rate varies from the federal statutory rate of 21%, primarily as a result of state tax expense, stock based compensation, foreign taxes and a research and development credit for the six months ended June 30, 2020 and 2019. We continue to maintain a valuation allowance against certain deferred tax assets, specifically for mining claims for PEVM, where realization is not certain.
The CARES Act provides stimulus measures to companies impacted by the COVID-19 pandemic, which include the ability to defer payment for employer payroll taxes, utilize net operating loss ("NOL") carrybacks, increased the limitation on the deductibility of interest expense, technical corrections to allow accelerated tax depreciation on qualified improvement property, as well as allowing qualified business to apply for loans and grants. We have recognized $16.5 million for the NOL carryback claims, which are included in the $16.2 million income tax receivable. On April 30, 2020 we filed our first refund claims for approximately $14.1 million and on June 30, 2020 we filed our second and final refund claims for approximately $2.4 million.
15. SEGMENT INFORMATION
We operate through business segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by our key decision maker, who is our Chief Executive Officer. Segment data may include rounding differences.
Our Specialty Petrochemicals segment includes SHR and GSPL. Our Specialty Waxes segment is TC. We also separately identify our corporate overhead which includes administrative activities such as legal, accounting, consulting, investor relations, officer and director compensation, corporate insurance, and other administrative costs.
Three Months Ended June 30, 2020 | |||||||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Eliminations | Consolidated | |||||||||||||||
(in thousands) | |||||||||||||||||||
Product sales | $ | $ | $ | $ | $ | ||||||||||||||
Processing fees | |||||||||||||||||||
Total revenues | |||||||||||||||||||
Operating income (loss) before depreciation and amortization | ( | ) | |||||||||||||||||
Operating income (loss) | ( | ) | ( | ) | ( | ) | |||||||||||||
Income (loss) from continuing operations before taxes | ( | ) | ( | ) | ( | ) | |||||||||||||
Depreciation and amortization | |||||||||||||||||||
Capital expenditures | |||||||||||||||||||
Three Months Ended June 30, 2019 | ||||||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Eliminations | Consolidated | ||||||||||||||
(in thousands) | ||||||||||||||||||
Product sales | $ | $ | $ | $ | ||||||||||||||
Processing fees | ||||||||||||||||||
Total revenues | ||||||||||||||||||
Operating income (loss) before depreciation and amortization | ( | ) | ||||||||||||||||
Operating income (loss) | ( | ) | ( | ) | ||||||||||||||
Income (loss) from continuing operations before taxes | ( | ) | ( | ) | ||||||||||||||
Depreciation and amortization | ||||||||||||||||||
Capital expenditures | ||||||||||||||||||
Six Months Ended June 30, 2020 | |||||||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Eliminations | Consolidated | |||||||||||||||
(in thousands) | |||||||||||||||||||
Product sales | $ | $ | $ | $ | $ | ||||||||||||||
Processing fees | |||||||||||||||||||
Total revenues | |||||||||||||||||||
Operating income (loss) before depreciation and amortization | ( | ) | |||||||||||||||||
Operating income (loss) | ( | ) | ( | ) | |||||||||||||||
Income (loss) from continuing operations before taxes | ( | ) | ( | ) | ( | ) | |||||||||||||
Depreciation and amortization | |||||||||||||||||||
Capital expenditures | |||||||||||||||||||
Six Months Ended June 30, 2019 | ||||||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Eliminations | Consolidated | ||||||||||||||
(in thousands) | ||||||||||||||||||
Product sales | $ | $ | $ | $ | ||||||||||||||
Processing fees | ||||||||||||||||||
Total revenues | ||||||||||||||||||
Operating income (loss) before depreciation and amortization | ( | ) | ( | ) | ||||||||||||||
Operating income (loss) | ( | ) | ( | ) | ||||||||||||||
Income (loss) from continuing operations before taxes | ( | ) | ( | ) | ||||||||||||||
Depreciation and amortization | ||||||||||||||||||
Capital expenditures | ||||||||||||||||||
June 30, 2020 | |||||||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Eliminations | Consolidated | |||||||||||||||
(in thousands) | |||||||||||||||||||
Trade receivables, product sales | $ | $ | $ | $ | $ | ||||||||||||||
Trade receivables, processing fees | |||||||||||||||||||
Intangible assets, net | |||||||||||||||||||
Total assets | ( | ) | |||||||||||||||||
December 31, 2019 | |||||||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Eliminations | Consolidated | |||||||||||||||
(in thousands) | |||||||||||||||||||
Trade receivables, product sales | $ | $ | $ | $ | $ | ||||||||||||||
Trade receivables, processing fees | |||||||||||||||||||
Intangible assets, net | |||||||||||||||||||
Total assets | ( | ) | |||||||||||||||||
16. NET INCOME (LOSS) PER COMMON SHARE
The following tables set forth the computation of basic and diluted net income (loss) per share for the three and six months ended June 30, 2020 and 2019, respectively.
Net Income (Loss) per Common Share - Continuing Operations
Three Months Ended June 30, 2020 | Three Months Ended June 30, 2019 | |||||||||||||||||||||
Income | Shares | Per Share Amount | Income | Shares | Per Share Amount | |||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||
Basic: | ||||||||||||||||||||||
Net income (loss) from continuing operations | $ | ( | ) | $ | ( | ) | $ | $ | ||||||||||||||
Unvested restricted stock units | ||||||||||||||||||||||
Diluted: | ||||||||||||||||||||||
Net income (loss) from continuing operations | $ | ( | ) | $ | ( | ) | $ | $ | ||||||||||||||
Six Months Ended June 30, 2020 | Six Months Ended June 30, 2019 | |||||||||||||||||||||
Income | Shares | Per Share Amount | Income | Shares | Per Share Amount | |||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||
Basic: | ||||||||||||||||||||||
Net income from continuing operations | $ | $ | $ | $ | ||||||||||||||||||
Unvested restricted stock units | ||||||||||||||||||||||
Diluted: | ||||||||||||||||||||||
Net income from continuing operations | $ | $ | $ | $ | ||||||||||||||||||
Net Income (Loss) per Common Share - Discontinued Operations
Three Months Ended June 30, 2020 | Three Months Ended June 30, 2019 | |||||||||||||||||||||
Income | Shares | Per Share Amount | Income (Loss) | Shares | Per Share Amount | |||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||
Basic: | ||||||||||||||||||||||
Net loss from discontinued operations, net of tax | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||||||||
Unvested restricted stock units | ||||||||||||||||||||||
Diluted: | ||||||||||||||||||||||
Net loss from discontinued operations, net of tax | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||||||||
Six Months Ended June 30, 2020 | Six Months Ended June 30, 2019 | |||||||||||||||||||||
Income (Loss) | Shares | Per Share Amount | Income (Loss) | Shares | Per Share Amount | |||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||
Basic: | ||||||||||||||||||||||
Net income (loss) from discontinued operations, net of tax | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||
Unvested restricted stock units | ||||||||||||||||||||||
Diluted: | ||||||||||||||||||||||
Net income (loss) from discontinued operations, net of tax | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||
Net Income (Loss) per Common Share
Three Months Ended June 30, 2020 | Three Months Ended June 30, 2019 | |||||||||||||||||||||
Income | Shares | Per Share Amount | Income | Shares | Per Share Amount | |||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||
Basic: | ||||||||||||||||||||||
Net income (loss) | $ | ( | ) | $ | ( | ) | $ | $ | ||||||||||||||
Unvested restricted stock units | ||||||||||||||||||||||
Diluted: | ||||||||||||||||||||||
Net income (loss) | $ | ( | ) | $ | ( | ) | $ | $ | ||||||||||||||
Six Months Ended June 30, 2020 | Six Months Ended June 30, 2019 | |||||||||||||||||||||
Income (Loss) | Shares | Per Share Amount | Income (Loss) | Shares | Per Share Amount | |||||||||||||||||
(in thousands, except per share amounts) | ||||||||||||||||||||||
Basic: | ||||||||||||||||||||||
Net income | $ | $ | $ | $ | ||||||||||||||||||
Unvested restricted stock units | ||||||||||||||||||||||
Diluted: | ||||||||||||||||||||||
Net income | $ | $ | $ | $ | ||||||||||||||||||
At June 30, 2020 and 2019, 487,000 and 552,000 shares of common stock, respectively, were issuable upon the exercise of options and warrants.
17. RELATED PARTY TRANSACTIONS
The Company incurred consulting fees of approximately nil and nil for the three months and nil and $0.1 million for the six months ended June 30, 2020 and 2019, respectively, from our Director, Nicholas Carter. Due to his history and experience with the Company and to provide continuity after his retirement, a consulting agreement was entered into with Mr. Carter in July 2015, which terminated effective December 31, 2019.
18. POST-RETIREMENT OBLIGATIONS
We currently have post-retirement obligations with two former executives. As of June 30, 2020 and December 31, 2019, approximately $0.3 million and $0.3 million, respectively, remained outstanding and was included in post-retirement obligations.
For additional information, see NOTE 22, “POST-RETIREMENT OBLIGATIONS” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2019.
19. SUBSEQUENT EVENTS
On July 28, 2020, the Company received proceeds of approximately $2.5 million in connection with the sale of a 1 million share portion of Trecora's overall ownership in AMAK. Following this transaction, the Company's ownership percentage in AMAK has been reduced from 28.3 % to 27.0 %.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
FORWARD LOOKING AND CAUTIONARY STATEMENTS
Some of the statements and information contained in this Quarterly Report on Form 10-Q may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding the Company's
financial position, business strategy and plans and objectives of the Company's management for future operations and other statements that are not historical facts, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as "outlook," "may," "will," "should," "could," "expects," "plans," "anticipates," "contemplates," "proposes," "believes," "estimates," "predicts," "projects," "potential," "continue," "intend," or the negative of such terms and other comparable terminology, or by discussions of strategy, plans or intentions.
Forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other important factors that could cause the actual results, performance or our achievements, or industry results, to differ materially from historical results, any future results, or performance or achievements expressed or implied by such forward–looking statements. Such risks, uncertainties and factors include, but are not limited to the impacts of: not completing, or not completely realizing the anticipated benefits from, the sale of our stake in AMAK; general economic and financial conditions domestically and internationally; insufficient cash flows from operating activities; our ability to attract and retain key employees; feedstock, product and mineral prices; feedstock availability and our ability to access third party transportation; competition; industry cycles; natural disasters or other severe weather events, health epidemics and pandemics (including the COVID-19 pandemic) and terrorist attacks; our ability to consummate extraordinary transactions, including acquisitions and dispositions, and realize the financial and strategic goals of such transactions; technological developments and our ability to maintain, expand and upgrade our facilities; regulatory changes; environmental matters; lawsuits; outstanding debt and other financial and legal obligations (including having to return the amounts borrowed under the PPP or failing to qualify for forgiveness of such loans, in whole or in part); difficulties in obtaining additional financing on favorable conditions, or at all; local business risks in foreign countries, including civil unrest and military or political conflict, local regulatory and legal environments and foreign currency fluctuations; and other risks detailed in our latest Annual Report on Form 10-K, including but not limited to: "Part I, Item 1A. Risk Factors" and "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" therein, and in our other filings with the Securities and Exchange Commission (the "SEC"). Many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 pandemic. Further, the COVID-19 pandemic may also affect our operating and financial results in a manner that is not presently known to us.
There may be other factors of which we are currently unaware or deem immaterial that may cause our actual results to differ materially from the forward-looking statements. In addition, to the extent any inconsistency or conflict exists between the information included in this report and the information included in our prior releases, reports and other filings with the SEC, the information contained in this report updates and supersedes such information.
Forward-looking statements are based on current plans, estimates, assumptions and projections, and, therefore, you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.
Overview
The following discussion and analysis of our financial results, as well as the accompanying unaudited condensed consolidated financial statements and related notes to consolidated financial statements to which they refer, are the responsibility of our management. Our accounting and financial reporting fairly reflect our business model which is based on the manufacturing and marketing of specialty petrochemical products and waxes and providing custom manufacturing services.
The discussion and analysis of financial condition and the results of operations which appears below should be read in conjunction with "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Annual Report on Form 10-K for the year ended December 31, 2019.
Our preferred supplier position into the specialty petrochemicals market is derived from the combination of our reputation as a reliable supplier established over many years, the very high purity of our products, and a focused approach to customer service. In specialty waxes, we are able to deliver to our customers a performance and price point that is unique to our market; while the diversity of our custom processing assets and capabilities offers solutions to our customers that we believe are uncommon along the U.S. Gulf Coast.
Enabling our success in these businesses is a commitment to operational excellence which establishes a culture that prioritizes the safety of our employees and communities in which we operate, the integrity of our assets and regulatory compliance. This commitment drives a change to an emphasis on forward-looking, leading-indicators of our results and proactive steps to continuously improve our performance. We bring the same commitment to excellence to our commercial
activities where we focus on the value proposition to our customers while understanding opportunities to maximize our value capture through service and product differentiation, supply chain and operating cost efficiencies and diversified supply options. We believe our focus on execution, meeting the needs of our customers, and growing our business while maintaining prudent control of our costs, will significantly contribute to enhanced shareholder value.
Review of Second Quarter 2020 Results
The COVID-19 pandemic adversely impacted our second quarter results due to its global impact on economic demand. We reported second quarter 2020 net loss of $1.9 million, down from net income of $2.4 million in the second quarter of 2019. Diluted losses per share are $0.07 for the second quarter of 2020, down from earnings per share of $0.10 for the same period in 2019. Sales volume of our Specialty Petrochemicals products decreased 28.5% due to lower sales to the polyethylene end-use markets as well as lower sales to Canadian oil sands customers. Sales to other end-use markets were also generally weaker compared to the same period last year due to the COVID-19 pandemic. Specialty Waxes sales revenue was down 18.9% compared to the second quarter 2019 due to the impact on our customers from the COVID-19 pandemic.
Adjusted EBITDA from continuing operations was $4.2 million for the second quarter of 2020, compared with Adjusted EBITDA from continuing operations of $9.3 million in the second quarter of 2019. Adjusted EBITDA from continuing operations declined due to lower sales volumes for prime products and by-products in our Specialty Petrochemicals segment, as well as lower Specialty Waxes sales revenue, both of which were impacted by the COVID-19 pandemic.
COVID-19 Pandemic
The continued global impact of COVID-19 has resulted in various emergency measures to curb the spread of the virus. We continue to monitor the progression of the COVID-19 pandemic on a daily basis. Our guiding principle is, and has always been, the protection of our people and the communities in which we work, as well as maintaining the overall integrity of our assets. While our essential plant personnel remain on-site, many of our other employees are working remotely. We are continuing to follow the orders and guidance of federal, state, and local governmental agencies, as we maintain our own stringent protocols in an effort to mitigate the spread of the virus and protect the health of our employees, customers, and suppliers as well as the communities in which we work. As an organization, we adopted social distancing behaviors early, executed the necessary changes to enable all possible job duties to be performed remotely and rapidly identified and executed the necessary adjustments to support optimal productivity for all remote workers.
To date, our plants have continued to operate as normal, and our supply chain has generally remained intact, with adequate availability of raw materials. Importantly, under the U.S. Department of Homeland Security guidance issued on April 17, 2020, as well as many related state and local governmental orders, chemical manufacturing sites are considered essential critical infrastructure, and as such, are not currently subject to closure in the locations where we operate. Although there has been some disruption in global logistics channels, we have not experienced significant delays in fulfillment of customer orders.
The COVID-19 pandemic has had an impact on our business, results of operations, financial position and liquidity for the second quarter of 2020. In the second quarter, we saw reduced demand in certain end markets (in particular, durable goods such as automotive and construction), which we attribute to the economic slowdown caused by the COVID-19 pandemic. This weakened demand in certain end markets is likely to continue in the near-term and may continue for the remainder of 2020, and could spread more broadly to our other end markets, depending on the magnitude and duration of the impact of the COVID-19 pandemic. As a result, we are unable to accurately predict the impact that the pandemic for the remainder of 2020 and, potentially, beyond (including how the impact of the pandemic may change from quarter to quarter). However, we believe our long-term demand thereafter remains intact.
Our management will continue to actively monitor the impact of the global situation on our business, results of operations, financial condition, liquidity, suppliers, industry, investments, and workforce. We do not currently anticipate any material impairments, with respect to intangible assets, long–lived assets, or right of use assets, increases in allowances for credit losses from our customers, restructuring charges, other expenses, or changes in accounting judgments to have a material impact on our condensed consolidated financial statements, however at this point we are continuing to assess the impact, if any.
Non-GAAP Financial Measures
We include in this Quarterly Report on Form 10-Q the non-GAAP financial measures of EBITDA from continuing operations and Adjusted EBITDA from continuing operations and provide reconciliations from our most directly comparable GAAP financial measures to those measures.
We believe these financial measures provide users of our financial statements with supplemental information that may be useful in evaluating our operating performance. We also believe that such non–GAAP measures, when read in conjunction with our operating results presented under GAAP, can be used to better assess our performance from period to period and relative to performance of other companies in our industry, without regard to financing methods, historical cost basis or capital structure. These measures are not measures of financial performance or liquidity under GAAP and should be considered in addition to, and not as a substitute for, analysis of our results under GAAP.
We define EBITDA from continuing operations as net income (loss) from continuing operations plus interest expense (benefit), income taxes, depreciation and amortization. We define Adjusted EBITDA from continuing operations as EBITDA from continuing operations plus share–based compensation, plus restructuring and severance expenses, plus or minus equity in AMAK's earnings and losses, plus impairment losses and plus or minus gains or losses on disposal of assets.
The following table presents a reconciliation of net income (loss), our most directly comparable GAAP financial performance measure for each of the periods presented, to EBITDA from continuing operations and Adjusted EBITDA from continuing operations.
Three Months Ended June 30, 2020 | |||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Consolidated | ||||||||||||
(in thousands) | |||||||||||||||
Net Income (Loss) | $ | 1,393 | $ | (332 | ) | $ | (2,922 | ) | $ | (1,861 | ) | ||||
Loss from discontinued operations, net of tax | — | — | (2 | ) | (2 | ) | |||||||||
Income (loss) from continuing operations | $ | 1,393 | $ | (332 | ) | $ | (2,920 | ) | $ | (1,859 | ) | ||||
Interest | 736 | — | (1 | ) | 735 | ||||||||||
Income tax expense (benefit) | 255 | (113 | ) | 716 | 858 | ||||||||||
Depreciation and amortization | 185 | 23 | 4 | 212 | |||||||||||
Depreciation and amortization in cost of sales | 2,436 | 1,314 | — | 3,750 | |||||||||||
EBITDA from continuing operations | $ | 5,005 | $ | 892 | $ | (2,201 | ) | $ | 3,696 | ||||||
Stock-based compensation | — | — | 543 | 543 | |||||||||||
Gain on disposal of assets | (7 | ) | — | — | (7 | ) | |||||||||
Adjusted EBITDA from continuing operations | $ | 4,998 | $ | 892 | $ | (1,658 | ) | $ | 4,232 | ||||||
Three Months Ended June 30, 2019 | |||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Consolidated | ||||||||||||
(in thousands) | |||||||||||||||
Net Income (Loss) | $ | 4,666 | $ | (1,013 | ) | $ | (1,249 | ) | $ | 2,404 | |||||
Loss from discontinued operations, net of tax | — | — | (103 | ) | (103 | ) | |||||||||
Income (Loss) from continuing operations | $ | 4,666 | $ | (1,013 | ) | $ | (1,146 | ) | $ | 2,507 | |||||
Interest | 1,053 | 347 | 1 | 1,401 | |||||||||||
Income tax expense (benefit) | 1,709 | — | (1,018 | ) | 691 | ||||||||||
Depreciation and amortization | 172 | 24 | 12 | 208 | |||||||||||
Depreciation and amortization in cost of sales | 2,753 | 1,375 | — | 4,128 | |||||||||||
EBITDA from continuing operations | $ | 10,353 | $ | 733 | $ | (2,151 | ) | $ | 8,935 | ||||||
Stock-based compensation | — | — | 345 | 345 | |||||||||||
Adjusted EBITDA from continuing operations | $ | 10,353 | $ | 733 | $ | (1,806 | ) | $ | 9,280 | ||||||
Six Months Ended June 30, 2020 | |||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Consolidated | ||||||||||||
(in thousands) | |||||||||||||||
Net Income | $ | 5,989 | $ | 882 | $ | 1,988 | $ | 8,859 | |||||||
Income from discontinued operations, net of tax | — | — | 4,855 | 4,855 | |||||||||||
Income (loss) from continuing operations | $ | 5,989 | $ | 882 | $ | (2,867 | ) | $ | 4,004 | ||||||
Interest | 1,651 | — | — | 1,651 | |||||||||||
Income tax benefit | (1,399 | ) | (1,569 | ) | (1,827 | ) | (4,795 | ) | |||||||
Depreciation and amortization | 371 | 47 | 10 | 428 | |||||||||||
Depreciation and amortization in cost of sales | 4,867 | 2,619 | — | 7,486 | |||||||||||
EBITDA from continuing operations | $ | 11,479 | $ | 1,979 | $ | (4,684 | ) | $ | 8,774 | ||||||
Stock-based compensation | — | — | 933 | 933 | |||||||||||
(Gain) Loss on disposal of assets | (8 | ) | 17 | — | 9 | ||||||||||
Adjusted EBITDA from continuing operations | $ | 11,471 | $ | 1,996 | $ | (3,751 | ) | $ | 9,716 | ||||||
Six Months Ended June 30, 2019 | |||||||||||||||
Specialty Petrochemicals | Specialty Waxes | Corporate | Consolidated | ||||||||||||
(in thousands) | |||||||||||||||
Net Income (Loss) | $ | 10,808 | $ | (3,552 | ) | $ | (3,101 | ) | $ | 4,155 | |||||
Loss from discontinued operations, net of tax | — | — | (162 | ) | (162 | ) | |||||||||
Income (loss) from continuing operations | $ | 10,808 | $ | (3,552 | ) | $ | (2,939 | ) | $ | 4,317 | |||||
Interest | 2,248 | 651 | 1 | 2,900 | |||||||||||
Income tax expense (benefit) | 2,703 | — | (1,518 | ) | 1,185 | ||||||||||
Depreciation and amortization | 341 | 48 | 32 | 421 | |||||||||||
Depreciation and amortization in cost of sales | 5,658 | 2,699 | — | 8,357 | |||||||||||
EBITDA from continuing operations | $ | 21,758 | $ | (154 | ) | $ | (4,424 | ) | $ | 17,180 | |||||
Stock-based compensation | — | — | 558 | 558 | |||||||||||
Adjusted EBITDA from continuing operations | $ | 21,758 | $ | (154 | ) | $ | (3,866 | ) | $ | 17,738 | |||||
Liquidity and Capital Resources
Working Capital
Our approximate working capital days are summarized as follows:
June 30, 2020 | December 31, 2019 | June 30, 2019 | ||||||
Days sales outstanding in accounts receivable | 45.3 | 37.1 | 41.1 | |||||
Days sales outstanding in inventory | 17.0 | 19.2 | 20.6 | |||||
Days sales outstanding in accounts payable | 24.7 | 20.6 | 15.0 | |||||
Days of working capital | 37.6 | 35.7 | 46.6 | |||||
Our days sales outstanding in accounts receivable at June 30, 2020 was 45.3 days compared to 37.1 days at December 31, 2019, driven by administrative processing delays. Our days sales outstanding in inventory decreased by approximately 2.2 days from December 31, 2019, driven by lower inventory values based on reduced feedstock prices. Our days sales outstanding in accounts payable increased due to a reduced payable to our feedstock supplier driven by lower feedstock prices, as well as payments to vendors in the first quarter of 2020 for costs associated with the weather event in the fourth quarter of 2019, which caused severe damage to one of the feedstock storage tanks at our Silsbee plant. Since days of working capital is calculated using the above three metrics, it increased for the aforementioned reasons discussed.
Our cash balance at June 30, 2020 was $29.9 million, an increase of $25.6 million from same period in 2019. Improved working capital due to lower feedstock costs provided approximately $7.5 million during the six month ended June 30, 2020. Additionally, our cash balance included $10.1 million of proceeds from the sale of AMAK shares to Arab Mining Company and PPP Loans of $6.1 million.
The change in cash is summarized as follows:
Six Months Ended June 30, | ||||||||
2020 | 2019 | |||||||
Net cash provided by (used in) | (thousands of dollars) | |||||||
Operating activities | $ | 20,555 | $ | 5,848 | ||||
Investing activities | 2,312 | (3,842 | ) | |||||
Financing activities | 865 | (4,416 | ) | |||||
Increase (decrease) in cash | $ | 23,732 | $ | (2,410 | ) | |||
Cash | $ | 29,877 | $ | 4,325 | ||||
Operating Activities
Cash provided by operating activities totaled $20.6 million for the first six months of 2020, $14.7 million higher than the corresponding period in 2019. For the first six months of 2020 net income increased by approximately $4.7 million as compared to the corresponding period in 2019. Major non-cash items affecting income in the first six months of 2020 included changes in depreciation and amortization of $7.9 million, deferred taxes of $11.1 million and stock-based compensation of $0.9 million. Major non-cash items affecting income in the first six months of 2019 included deferred taxes of $1.0 million and depreciation and amortization of $8.8 million.
Additional factors leading to an increase in cash provided by operating activities included:
• | Under the CARES Act, we recorded an income tax receivable related to the carryback of NOL claims. This resulted in an increase in our income tax receivable of approximately $15.7 million. On April 30, 2020 we filed our first refund claims for approximately $14.1 million and on June 30, 2020 we filed our second and final refund claims for approximately $2.4 million. |
• | Trade receivables decreased approximately $6.1 million. This is due to lower sales within the quarter and we do not expect any collection issues at this time. |
• | Inventories decreased approximately $6.0 million driven by lower inventory values associated with the continued decline in feedstock prices. |
• | Accounts payable and accrued liabilities decreased $1.8 million primarily due to a reduced payable to our feedstock supplier driven by lower feedstock prices, as well as payments to vendors in the first quarter of 2020 for costs associated with the aforementioned weather event in the fourth quarter of 2019. |
Investing Activities
Cash provided by investing activities during the first six months of 2020 was approximately $2.3 million, representing an increase of approximately $6.2 million from the corresponding period of 2019. The primary source of the funds provided by investing activities was $10.2 million of proceeds, net of the deposit previously paid, received in connection with the First Closing of the sale of our investment in AMAK discussed in Note 5, offset by additions of plant, pipeline and equipment of approximately $7.9 million.
Financing Activities
Cash provided by financing activities during the first six months of 2020 was approximately $0.9 million versus cash used in financing activities of $4.4 million during the corresponding period of 2019. In the first half of 2020, we drew $20.0 million under our Revolving Facility as a precaution in light of the uncertainty caused by the COVID–19 pandemic. We also received PPP Loans of $6.1 million to maintain the continuity of our workforce, including maintaining compensation and benefits. In light of improving liquidity and business conditions, we repaid our outstanding balance on our Revolving Facility of $23 million at the end of the quarter. We also made mandatory payments of $2.2 million on our Term Loan Facility. During the first half of 2019, we made principal payments on our outstanding Credit Facilities of $6.2 million. We drew $2.0 million on our line of credit for working capital purposes in the first six months of 2019.
Anticipated Cash Needs
The COVID-19 pandemic has resulted in significant economic uncertainty and market volatility. In response, we have taken steps to address our liquidity needs during this uncertain period. In the first quarter of 2020 we drew $20.0 million under our Revolving Facility as a precautionary measure and, as of June 30, 2020, we are carrying approximately $29.9 million in cash, combined with an available balance on our Revolving Facility of approximately $27 million. We also benefited from certain provisions of the CARES Act, including certain changes to U.S. tax law and borrowings under the PPP Loans that we believe will be essential to support the continuity of our workforce. As a result, we believe, given current business conditions, the Company is capable of supporting its operating requirements and capital expenditures through internally generated funds supplemented with cash on our balance sheet and potential future borrowings under our ARC Agreement.
Results of Operations
Comparison of Three Months Ended June 30, 2020 and 2019
Specialty Petrochemicals Segment
Three Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
Product Sales | $ | 31,236 | $ | 58,584 | $ | (27,348 | ) | (46.7 | )% | ||||||
Processing | 1,159 | 1,527 | (368 | ) | (24.1 | )% | |||||||||
Gross Revenue | $ | 32,395 | $ | 60,111 | $ | (27,716 | ) | (46.1 | )% | ||||||
Volume of Sales (gallons) | |||||||||||||||
Specialty Petrochemicals Products | 15,343 | 21,447 | (6,104 | ) | (28.5 | )% | |||||||||
Prime Product Sales | 13,090 | 17,732 | (4,642 | ) | (26.2 | )% | |||||||||
By-product Sales | 2,253 | 3,715 | (1,462 | ) | (39.4 | )% | |||||||||
Cost of Sales | $ | 27,126 | $ | 50,049 | (22,923 | ) | (45.8 | )% | |||||||
Gross Margin | 16.3 | % | 16.7 | % | (0.4 | )% | |||||||||
Total Operating Expense* | 16,160 | 18,455 | (2,295 | ) | (12.4 | )% | |||||||||
Natural Gas Expense* | 685 | 1,253 | (568 | ) | (45.3 | )% | |||||||||
Operating Labor Costs* | 3,932 | 3,596 | 336 | 9.3 | % | ||||||||||
Transportation Costs* | 4,890 | 7,360 | (2,470 | ) | (33.6 | )% | |||||||||
General & Administrative Expense | 2,730 | 2,816 | (86 | ) | (3.1 | )% | |||||||||
Depreciation and Amortization** | 2,621 | 2,925 | (304 | ) | (10.4 | )% | |||||||||
Capital Expenditures | 5,382 | 1,461 | 3,921 | 268.4 | % | ||||||||||
* Included in cost of sales
**Includes $2,435 and $2,753 for 2020 and 2019, respectively, which is included in operating expense
Gross Revenue
Gross Revenue for our Specialty Petrochemicals segment decreased during the second quarter 2020 from the second quarter 2019 by 46.1% primarily due to lower sales volumes for prime products and by-products which was impacted by the COVID-19 pandemic. Also, gross revenue was reduced by lower selling prices resulting from a decrease in feedstock costs relative to the same period a year ago.
Product Sales
Specialty Petrochemicals segment product sales declined approximately 46.7% during the second quarter 2020 from the second quarter 2019. Prime products sales volume declined approximately 4.6 million gallons, or 26.2%, from the second quarter 2019 due to lower demand from polyethylene end-use markets as well as lower sales to Canadian oil sands customers. Sales to other end-use markets were also generally weaker compared to the same period last year due to the COVID-19 pandemic. By-product sales volumes in second quarter 2020 declined 39% compared to the second quarter 2019 mainly due to lower prime product production and sales. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume decreased to 20.8% of total Specialty Petrochemicals volume in the second quarter for 2020 from 24.7% in the second quarter 2019. Foreign sales volume includes sales to Canadian oil sands customers.
Processing
Processing revenues were $1.2 million in the second quarter 2020 compared to $1.5 million for the second quarter 2019.
Cost of Sales (includes but is not limited to raw materials and total operating expense)
We use natural gasoline as feedstock, which is the heavier liquid remaining after ethane, propane and butanes are removed from liquids produced by natural gas wells. The material is a commodity product in the oil/petrochemical markets and generally is readily available. The price of natural gasoline is highly correlated with the price of crude oil. Our Advanced
Reformer unit upgrades the by-product stream produced as a result of prime product production. This upgrade allows us to sell our by-products at higher prices than would be possible without the Advanced Reformer unit.
Cost of Sales declined 45.8% during the second quarter 2020 from the second quarter 2019. The decline in cost of sales compared to the same period last year was driven by depressed sales volumes, lower feedstock costs and lower operating expenses - primarily transportation and natural gas costs. Benchmark Mount Belvieu natural gasoline feedstock price declined 65% from $1.20 per gallon in second quarter 2019 to $0.42 per gallon in the second quarter 2020. As a result of the sharp decline in feedstock cost compared to second quarter of 2019 our average margin for prime products increased. By-product margins were materially lower compared to second quarter 2019. This was primarily due to lower component prices combined with the inability to take full advantage during the quarter of the product upgrade capability of the Advanced Reformer unit due to production rates below minimum threshold required for Advanced Reformer unit operation.
The gross margin percentage for the Specialty Petrochemicals segment decreased from 16.7% in the second quarter of 2019 to 16.3% in the second quarter of 2020 mainly because of fixed costs being spread over lower sales volumes in the second quarter of 2020.
Total Operating Expense (includes but is not limited to natural gas, operating labor, depreciation and transportation)
Total Operating Expense decreased $2.3 million, or 12.4%, during the second quarter 2020 from the same period in 2019. Operating expense in the quarter benefited primarily from lower transportation costs.
Capital Expenditures
Capital expenditures in the second quarter 2020 were approximately $5.4 million compared to $1.5 million in the second quarter of 2019. Second quarter 2020 included approximately $3.6 million for maintenance and upkeep of our GSPL pipeline which is used to transport our feedstock.
Specialty Waxes Segment
Three Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
Product Sales | $ | 5,471 | $ | 6,745 | $ | (1,274 | ) | (18.9 | )% | ||||||
Processing | 2,808 | 2,515 | 293 | 11.7 | % | ||||||||||
Gross Revenue | $ | 8,279 | $ | 9,260 | $ | (981 | ) | (10.6 | )% | ||||||
Volume of specialty wax sales (thousand pounds) | 8,366 | 9,955 | (1,589 | ) | (16.0 | )% | |||||||||
Cost of Sales | $ | 7,381 | $ | 8,757 | $ | (1,376 | ) | (15.7 | )% | ||||||
Gross Margin (Loss) | 10.8 | % | 5.4 | % | 5.4 | % | |||||||||
General & Administrative Expense | 1,359 | 1,083 | 276 | 25.5 | % | ||||||||||
Depreciation and Amortization* | 1,338 | 1,399 | (61 | ) | (4.4 | )% | |||||||||
Capital Expenditures | $ | 285 | $ | 426 | $ | (141 | ) | (33.1 | )% | ||||||
*Includes $1,314 and $1,357 for 2020 and 2019, respectively, which is included in cost of sales
Product Sales
Product sales revenue for the Specialty Waxes segment decreased 18.9% during the second quarter 2020 from the second quarter 2019 as specialty wax sales volume declined nearly 1.6 million pounds. In the second quarter 2020 wax sales were depressed due to the impact on our customers from the COVID-19 pandemic. Many of our customers, especially in the automotive, furniture and construction end-markets, had significant decline in sales demand due to the pandemic. There were no material disruptions to feed supply during the second quarter of 2020. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast.
Processing
Processing revenues were $2.8 million in the second quarter 2020, a $0.3 million increase from the second quarter 2019.
Cost of Sales
Cost of Sales decreased 15.7%, or nearly $1.4 million, in the second quarter 2020 compared to the second quarter 2019. This decrease was driven by a decline in polyethylene wax feed cost and lower operating expenses.
Depreciation
Depreciation for the second quarter 2020 was $1.3 million, relatively flat from second quarter 2019.
Capital Expenditures
Capital Expenditures were approximately $0.3 million in the second quarter 2020 compared with $0.4 million in the second quarter of 2019.
Corporate Segment
Three Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
General & Administrative Expense | $ | 2,200 | $ | 2,182 | $ | 18 | 0.8 | % | |||||||
General corporate expenses were relatively flat from the second quarter 2019.
Investment in AMAK - Discontinued Operations
Three Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
Equity in earnings (losses) of AMAK | $ | 306 | $ | (91 | ) | $ | 397 | 436.3 | % | ||||||
Equity in earnings (losses) of AMAK include amortization of the difference between the Company's investment in AMAK and the Company's share of net assets of AMAK. For the second quarter 2020, equity in earnings (losses) of AMAK were immaterial and increased slightly from second quarter 2019.
AMAK Summarized Income Statement
Three Months Ended June 30, | ||||||||
2020 | 2019 | |||||||
(thousands of dollars) | ||||||||
Sales | $ | 20,752 | $ | 20,566 | ||||
Cost of sales | 17,829 | 18,162 | ||||||
Gross profit | 2,923 | 2,404 | ||||||
Selling, general, and administrative | 2,362 | 2,807 | ||||||
Operating loss | 561 | (403 | ) | |||||
Other income | — | (75 | ) | |||||
Finance and interest expense | (103 | ) | (448 | ) | ||||
Loss before Zakat and income taxes | 458 | (926 | ) | |||||
Zakat and income taxes | 566 | 366 | ||||||
Net Loss | $ | (108 | ) | $ | (1,292 | ) | ||
Finance and interest expense | 103 | 448 | ||||||
Depreciation and amortization | 6,393 | 7,746 | ||||||
Zakat and income taxes | 566 | 366 | ||||||
EBITDA | $ | 6,954 | $ | 7,268 | ||||
Approximately 18,000 dry metric tons (dmt) of copper and zinc concentrate were shipped in the second quarter 2020 as compared to 17,000 dmt of copper and zinc concentrate in the second quarter 2019.
Results of Operations
Comparison of Six Months Ended June 30, 2020 and 2019
Specialty Petrochemicals Segment
Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
Product Sales | $ | 81,622 | $ | 114,074 | $ | (32,452 | ) | (28.4 | )% | ||||||
Processing | 2,403 | 2,910 | (507 | ) | (17.4 | )% | |||||||||
Gross Revenue | $ | 84,025 | $ | 116,984 | $ | (32,959 | ) | (28.2 | )% | ||||||
Volume of Sales (gallons) | |||||||||||||||
Specialty Petrochemicals Products | 35,084 | 43,915 | (8,831 | ) | (20.1 | )% | |||||||||
Prime Product Sales | 29,309 | 35,370 | (6,061 | ) | (17.1 | )% | |||||||||
By-product Sales | 5,775 | 8,545 | (2,770 | ) | (32.4 | )% | |||||||||
Cost of Sales | $ | 71,922 | $ | 95,915 | (23,993 | ) | (25.0 | )% | |||||||
Gross Margin | 14.4 | % | 18.0 | % | (3.6 | )% | |||||||||
Total Operating Expense* | 32,900 | 36,735 | (3,835 | ) | (10.4 | )% | |||||||||
Natural Gas Expense* | 1,612 | 2,636 | (1,024 | ) | (38.8 | )% | |||||||||
Operating Labor Costs* | 7,937 | 7,299 | 638 | 8.7 | % | ||||||||||
Transportation Costs* | 9,777 | 14,408 | (4,631 | ) | (32.1 | )% | |||||||||
General & Administrative Expense | 5,506 | 5,291 | 215 | 4.1 | % | ||||||||||
Depreciation and Amortization** | 5,238 | 5,999 | (761 | ) | (12.7 | )% | |||||||||
Capital Expenditures | 6,983 | 2,839 | 4,144 | 146.0 | % | ||||||||||
* Included in cost of sales
**Includes $4,867 and $5,658 for 2020 and 2019, respectively, which is included in operating expense
Gross Revenue
Gross Revenue for our Specialty Petrochemicals segment decreased during the second quarter 2020 from the second quarter 2019 by 28.2% primarily due to lower sales volumes for prime products and byproducts as a result of the COVID-19 pandemic and its general impact on the economy. A decrease in average selling prices resulting from a decrease in feedstock costs also contributed to the revenue decline.
Product Sales
Specialty Petrochemicals segment product sales declined approximately 28.4% during the first half of 2020 from the first half of 2019 primarily as a result of the COVID-19 pandemic. Prime products sales volume declined approximately 6.1 million gallons or 17.1% from the first half of 2019 due to lower demand from the polyethylene end-use markets as well as lower sales to Canadian oil sands customers. Sales to other end-use markets were also generally weaker compared to the same period last year. By-product sales volumes in the first half of 2020 declined 32.4% compared to the first half of 2019 mainly due to lower prime product production and sales. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume decreased to 20.8% of total Specialty Petrochemicals volume in the first half of 2020 from 24.7% in the first half of 2019. Foreign sales volume includes sales to Canadian oil sands customers.
Processing
Processing revenues were approximately $2.4 million and $2.9 million for the first half of 2020 and 2019, respectively.
Cost of Sales (includes but is not limited to raw materials and total operating expense)
Cost of Sales declined 25.0% during the first half of 2020 from the first half of 2019. The decline in cost of sales compared to the same period last year was driven by depressed sales volumes, lower feedstock costs and lower operating expenses - primarily natural gas and transportation costs. Benchmark Mount Belvieu natural gasoline feedstock price declined 42% from
$1.17 per gallon in the first half of 2019 to $0.68 per gallon in the first half of 2020. By-product margins were lower compared to the first half of 2019. This was primarily due to lower component prices combined with the inability to take full advantage during the the first half of 2020 of the product upgrade capability of the Advance Reformer unit due to production rates below minimum threshold required for Advance Reformer unit operation.
The gross margin percentage for the Specialty Petrochemicals segment decreased from 18.0% in the first half of 2019 to 14.4% in the first half of 2020 driven by fixed cost being spread over lower sales volume.
Total Operating Expense (includes but is not limited to natural gas, operating labor, depreciation and transportation)
Total Operating Expense decreased $3.8 million, or 10.4%, during the first half of 2020 from the same period in 2019. Operating expense in the quarter benefited from lower transportation and natural gas costs.
Capital Expenditures
Capital expenditures in the first half of 2020 were approximately $7.0 million compared to $2.8 million in the first half of 2019. The first half of 2020 included approximately $4.5 million for maintenance and upkeep of our GSPL pipeline which is used to transport our feedstock.
Specialty Waxes Segment
Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
Product Sales | $ | 12,268 | $ | 12,748 | $ | (480 | ) | (3.8 | )% | ||||||
Processing | 6,448 | 4,794 | 1,654 | 34.5 | % | ||||||||||
Gross Revenue | $ | 18,716 | $ | 17,542 | $ | 1,174 | 6.7 | % | |||||||
Volume of specialty wax sales (thousand pounds) | 18,540 | 17,837 | 703 | 3.9 | % | ||||||||||
Cost of Sales | $ | 16,574 | $ | 17,973 | $ | (1,399 | ) | (7.8 | )% | ||||||
Gross Margin (Loss) | 11.4 | % | (2.5 | )% | 13.9 | % | |||||||||
General & Administrative Expense | 2,842 | 2,352 | 490 | 20.8 | % | ||||||||||
Depreciation and Amortization* | 2,666 | 2,747 | (81 | ) | (2.9 | )% | |||||||||
Capital Expenditures | $ | 601 | $ | 935 | $ | (334 | ) | (35.7 | )% | ||||||
*Includes $2,619 and $2,699 for 2020 and 2019, respectively, which is included in cost of sales
Product Sales
Specialty Wax segment product sales revenue decreased 3.8% during the first half of 2020 from the first half of 2019. In the first half of 2020 demand for our specialty wax products was negatively impacted due to the COVID-19 pandemic. Specialty wax sales volume increased 3.9% or nearly 0.7 million pounds. In the first half of 2019 planned maintenance turnaround at our Pasadena facility, along with outages at multiple wax feed suppliers, constrained specialty wax production and thereby sales volumes. There were no material disruptions to feed supply during the first half of 2020. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast.
Processing
Processing revenues were $6.4 million in the first half of 2020, a 34.5% or about $1.7 million increase from the first half of 2019. The increase was due to significantly improved operation of the hydrogenation/distillation unit as well as strong revenues from other custom processing customers in the first quarter of 2020.
Cost of Sales
Cost of Sales were decreased 7.8%, or nearly $1.4 million, in the first half of 2020 compared to the first half of 2019. This decrease was driven by lower polyethylene wax feed cost and reduced operating expenses.
Depreciation
Depreciation for the first half of 2020 was $2.7 million, relatively flat from the first half of 2019.
Capital Expenditures
Capital Expenditures were approximately $0.6 million in the first half of 2020 compared with $0.9 million in the first half of 2019.
Corporate Segment
Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
General & Administrative Expense | $ | 4,615 | $ | 4,487 | $ | 128 | 2.9 | % | |||||||
General corporate expenses increased by $0.1 million during the first half of 2020 from the first half of 2019. The increase is primarily attributable to stock-based compensation.
Investment in AMAK - Discontinued Operations
Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | Change | % Change | ||||||||||||
(thousands of dollars) | |||||||||||||||
Equity in losses of AMAK | $ | (226 | ) | $ | (150 | ) | $ | (76 | ) | 50.7 | % | ||||
Equity in losses of AMAK increased during the first half of 2020 from the first half of 2019. The equity in losses were primarily impacted by reduced sales resulting from a decrease in metal prices during the first half of the year.
AMAK Summarized Income Statement
Six Months Ended June 30, | ||||||||
2020 | 2019 | |||||||
(thousands of dollars) | ||||||||
Sales | $ | 38,689 | $ | 41,230 | ||||
Cost of sales | 34,650 | 36,732 | ||||||
Gross profit | 4,039 | 4,498 | ||||||
Selling, general, and administrative | 5,042 | 5,545 | ||||||
Operating loss | (1,003 | ) | (1,047 | ) | ||||
Other income | 17 | 353 | ||||||
Finance and interest expense | (634 | ) | (893 | ) | ||||
Loss before Zakat and income taxes | (1,620 | ) | (1,587 | ) | ||||
Zakat and income taxes | 1,099 | 888 | ||||||
Net Loss | $ | (2,719 | ) | $ | (2,475 | ) | ||
Finance and interest expense | 634 | 893 | ||||||
Depreciation and amortization | 13,722 | 15,070 | ||||||
Zakat and income taxes | 1,099 | 888 | ||||||
EBITDA | $ | 12,736 | $ | 14,376 | ||||
Approximately 18,000 dry metric tons (dmt) of copper and zinc concentrate were shipped in the first half of 2020 as compared to 17,000 dmt of copper and zinc concentrate in the first half of 2019. Reduced depreciation and amortization expenses were the primary factors in the decline of EBITDA of approximately $1.6 million relative to the first half of 2019.
Contractual Obligations
Our contractual obligations are summarized in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations," in our Annual Report on Form 10-K for the year ended December 31, 2019. There have been no other material changes to the contractual obligation amounts disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019.
Critical Accounting Policies and Estimates
Critical accounting policies are more fully described in Note 2, “RECENT ACCOUNTING PRONOUNCEMENTS” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2019. The preparation of consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period reported. By their nature, these estimates, assumptions and judgments are subject to an inherent degree of uncertainty. We base our estimates, assumptions and judgments on historical experience, market trends and other factors that are believed to be reasonable under the circumstances. Estimates, assumptions and judgments are reviewed on an ongoing basis and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies and estimates have been discussed with the Audit Committee of the Board of Directors and discussed in our Annual Report on Form 10-K for the year ended December 31, 2019. For the six months ended June 30, 2020, there were no significant changes to these policies.
Recent and New Accounting Standards
See Note 2 to the Condensed Consolidated Financial Statements for a summary of recent accounting guidance.
Off Balance Sheet Arrangements
Off balance sheet arrangements as defined by the SEC means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with the registrant is a party, under which the registrant has (i) obligations under certain guarantees or contracts, (ii) retained or contingent interest in assets transferred to an unconsolidated entity or similar arrangements, (iii) obligations under certain derivative arrangements, and (iv) obligations arising out of a material variable interest in an unconsolidated entity. Our guarantee for AMAK's debt is considered an off balance sheet arrangement. Please see further discussion in Note 5 to the Condensed Consolidated Financial Statements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
For quantitative and qualitative disclosure about market risk, see Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk" in our Annual Report on Form 10–K for the year ended December 31, 2019. There have been no material changes in the Company's exposure to market risk from the disclosure included in such report.
ITEM 4. CONTROLS AND PROCEDURES.
(a) | Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Chief Financial Officer, with the participation of management, have evaluated the effectiveness of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934) and determined that our disclosure controls and procedures were effective as of the end of the period covered by this report. |
(b) | Changes in internal control. There were no significant changes in our internal control over financial reporting that occurred during the three months ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. |
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The Company is periodically named in legal actions arising from normal business activities. The Company evaluates the merits of these actions and, if it determines that an unfavorable outcome is probable and can be reasonably estimated, the Company will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.
ITEM 1A. RISK FACTORS.
Readers of this Quarterly Report on Form 10–Q should carefully consider the risks described in the Company's other reports and filings filed with or furnished to the SEC, including the Company's prior and subsequent reports on Forms 10–K, 10–Q and 8–K, in connection with any evaluation of the Company's financial position, results of operations and cash flows.
The risks and uncertainties in the Company's most recent Annual Report on Form 10–K are not the only risks that the Company faces. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect the Company's operations. Any of the risks, uncertainties, events or circumstances described therein could cause the Company's future financial condition, results of operations or cash flows to be adversely affected. There have been no material changes from the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, except as noted below.
The global outbreak of COVID-19 has had, and may continue to have, an adverse impact on the business, results of operations, financial position, and liquidity of the Company and/or its customers, suppliers, and other counterparties.
The COVID-19 pandemic has caused, and may continue to cause, a global slowdown of economic activity, particularly, reduced demand in durable goods markets such as automotive and construction, disruptions in global supply chains, significant economic uncertainty and volatility and disruption of financial markets. The COVID-19 pandemic is having an impact on the Company’s operations and financial performance, as well as on the operations and financial performance of many of the Company's customers and suppliers. Across all of our businesses, we are facing increased operational challenges from the need to protect employee health and safety by requiring restrictions on the movement of people, which can cause workplace disruptions, reduced productivity, operational disruptions or shutdowns, and the incurrence of additional costs. Due to the economic slowdown caused by the COVID-19 pandemic, we are also experiencing, and may continue experiencing, lower demand and volume for products and services from our customers, as well as potential restrictions or delays on deliveries of key raw materials from our suppliers. See "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations", for additional information on how we have been impacted and the steps we have taken in response.
Because the severity, magnitude and duration of the COVID-19 pandemic and its economic consequences are uncertain, rapidly changing and difficult to predict, the pandemic’s impact on the Company’s operations and financial performance, as well as its impact on our ability to successfully execute our business strategies and initiatives, remains uncertain and difficult to predict. Additionally, the ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business and individuals’ actions that have been and continue to be taken in response to the pandemic (including restrictions on travel and transport and human capital constraints); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; the weakening of demand in certain end markets; prolonged disruption in global logistics channels; global economic conditions and levels of economic growth; and the pace of recovery when the COVID-19 pandemic subsides. We expect that the longer the period of economic and global supply chain and disruption continues, the more material the impact could be on our business operations, financial performance and results of operations, and this could include potential charges, impairments and other adverse financial impacts in future periods.
As the COVID-19 pandemic continues to adversely affect our operating and financial results, it may also have the effect of heightening many of the other risks described in the risk factors in our Annual Report on Form 10-K for the year ended December 31, 2019 and subsequent Quarterly Reports on 10-Q. Further, the COVID-19 pandemic may also affect our operating and financial results in a manner that is not presently known to us.
The possibility that our PPP Loan obligation may not be forgiven could limit cash flow available for our operations and could adversely affect our ability to obtain additional financing if necessary.
As of June 30, 2020, we had nil in borrowings outstanding under the Revolving Facility and $78.8 million in borrowings outstanding under the Term Loan Facility. Pursuant to the terms of the ARC Agreement, we also have the option, at any time, to request an increase to the commitment under the Revolving Facility and/or the Term Loan Facility by an additional amount of up to $50.0 million in the aggregate, subject to lenders acceptance of the increased commitment and other conditions.
Although the agreements governing our existing indebtedness contain restrictions on the incurrence of additional indebtedness, these restrictions are subject to a number of important exceptions, and additional indebtedness that we may incur from time to time to finance projects or for other reasons in compliance with these restrictions could be substantial. If we incur significant additional indebtedness, the related risks that we face could increase.
For example, in May 2020, the Borrowers received loan proceeds in an aggregate principal amount of approximately $6.1 million under the PPP Loans, which may be partially or fully forgiven if we comply with the provisions of the CARES Act. However, since the enactment of the CARES Act, the Small Business Administration (the “SBA”) and the Treasury Department (“Treasury”) have issued numerous rules and additional guidance to implement the PPP, which continue to develop and change. As a result of this rapidly changing regulatory environment, it is difficult to determine and predict with certainty eligibility and available benefits under the PPP. We expect that our use of the proceeds of the PPP Loans is consistent with the intended purpose for the PPP Loans, such as maintaining the continuity of our workforce, including compensation and benefits. The SBA has, however, continued to issue regulations concerning the terms and conditions required for the forgiveness of the PPP Loans. For instance, on April 23, 2020, the SBA issued guidance that creates uncertainty as to whether a borrower can qualify to participate in the PPP when it may have access to other sources of liquidity, such as a public company with substantial market value and access to capital markets. Subsequently, on April 28, 2020, the Secretary of the Treasury and the SBA announced that the government will review all PPP loans in excess of $2 million for which the borrower applies for forgiveness.
As a result, no assurance can be provided whether we will obtain forgiveness of the PPP Loans in whole or in part. If we were to be audited and we are not successful in obtaining forgiveness of all or a portion of the PPP Loans, the unforgiven portion of such indebtedness could remain outstanding until the maturity which could reduce our liquidity.
Our current, or any future, indebtedness (including any unforgiven portion of the PPP Loans) could:
•limit our flexibility in planning for, or reacting to, changes in the markets in which we compete;
•place us at a competitive disadvantage relative to our competitors with less indebtedness;
•limit our ability to reinvest in our business;
•render us more vulnerable to general adverse economic, regulatory and industry conditions; and
•require us to dedicate a substantial portion of our cash flow to service our indebtedness.
Our ability to meet our cash requirements, including our debt service obligations, is dependent upon our ability to maintain our operating performance, which will be subject to general economic and competitive conditions and to financial, business and other factors, many of which are beyond our control. We cannot provide assurance that our business will generate sufficient cash flow from operations to fund our cash requirements and debt service obligations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Issuer Purchases of Equity Securities
Period | (a) Total Number of Shares (or Units) Purchased(1) | (b) Average Price Paid Per Share (or Unit)(1) | (c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number (or Approximate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Programs | ||||||||
April 1, 2020 - April 30, 2020 | — | $ | — | — | — | |||||||
May 1, 2020 - May 31, 2020 | 2,456 | 4.44 | — | — | ||||||||
June 1, 2020 - June 30, 2020 | 3,547 | 6.22 | — | — | ||||||||
Total | 6,003 | $ | 5.49 | — | — | |||||||
(1) Represents shares of our common stock withheld for satisfaction of tax liabilities of a holder of restricted shares. The value of such shares was calculated based on the closing price of our common stock on the New York Stock Exchange on the date when the withholding was made. | ||||||||||||
ITEM 6. EXHIBITS.
The following documents are filed or incorporated by reference as exhibits to this Report. Exhibits marked with an asterisk (*) are filed herewith. Exhibits marked with a plus sign (+) are management contracts or a compensatory plan, contract or arrangement. The below exhibit marked with a degree sign (°) has been redacted in part, in compliance with Regulation S-K Item 601. The Company agrees to furnish supplementally an unredacted copy of such exhibit to the Securities and Exchange Commission upon its request.
Exhibit Number | Description |
10.1* | |
10.2* | |
10.3* | |
10.4*° | |
10.5*+ | |
31.1* | |
31.2* | |
32.1* | |
32.2* | |
101.INS* | XBRL Instance Document (XBRL tags are embedded within the Inline XBRL document) |
101.SCH* | XBRL Taxonomy Schema Document |
101.CAL* | XBRL Taxonomy Calculation Linkbase Document |
101.LAB* | XBRL Taxonomy Label Linkbase Document |
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document |
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document |
104* | Cover Page Interactive Data File (formatted as inline XBRL and included as Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
TRECORA RESOURCES | ||
Dated: August 6, 2020 | By: | /s/ Sami Ahmad |
Sami Ahmad | ||
Principal Financial Officer and Duly Authorized Officer | ||